[Pharmacogenetics in practice].
Spigset
Olav
O
Avdeling for klinisk farmakologi, St. Olavs Hospital, 7006 Trondheim. olav.spigset@legemidler.no
D000925:Anticoagulants / Q000008:administration & dosage / Q000378:metabolism; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000378:metabolism; D065729:Cytochrome P-450 CYP2C9; D005838:Genotype; D006801:Humans; D019934:International Normalized Ratio; D010597:Pharmacogenetics; D014859:Warfarin / Q000008:administration & dosage / Q000378:metabolism
D000925:Anticoagulants; D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases